Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.
Gergely Tóth(University of Cambridge), Lisa McConlogue(Gladstone Institutes), Ted Yednock(Annexon Biosciences (United States)), Daniel Schwizer, Mitali A. Tambe(Purdue University West Lafayette), Amandine Berthet(Institut des Maladies Neurodégénératives), Stephen J. Ballaron(Sunesis (United States)), Hans-Dieter Junker(Laboratoire de Biophotonique et Pharmacologie), Shyra J. Gardai(College of San Mateo), Wenxian Mao, Nunilo Cremades(University of Cambridge), Michael F. Jobling, Jean‐Christophe Rochet(Purdue University West Lafayette), Thomas Neumann(University of St.Gallen), Renate Sekul(Laboratoire de Biophotonique et Pharmacologie), John Christodoulou(The University of Sydney), Carlos W. Bertoncini(University of Cambridge), Eliezer Masliah(University of California San Diego), Michael P. Bova, Jiahui Tao(University of California, San Francisco), David A. Agard(University of California, San Francisco), Xiaohua Chen(Zhejiang Sci-Tech University), Phuong Nguyen(Cancer Research Institute), Brian Spencer(University of Southern California), John P. Anderson(Sunesis (United States)), Wherly P. Hoffman(Sunesis (United States)), Dale Schenk(Athena Group (United States)), Inge Ott(Laboratoire de Biophotonique et Pharmacologie), Balázs Szőke, Mariano Tabios(Howard Hughes Medical Institute)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k